![Bruce Hironaka](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Bruce A. Hironaka was the founder of IgGenix, Inc., founded in 2019, where the title held was Chief Executive Officer & Director.
Mr. Hironaka is also the founder of Agenovir Corp.
Mr. Hironaka was President & Chief Executive Officer at Thios Pharmaceuticals, Inc. Mr. Hironaka completed undergraduate education at the University of California, Berkeley and graduate education including an MBA at Stanford University.
| Sociétés | Poste | Fin |
|---|---|---|
Agenovir Corp.
 Agenovir Corp. BiotechnologyHealth Technology Engages in research and development of human therapeutics for the treatment of diseases | Fondateur | 08/12/2016 |
IgGenix, Inc.
 IgGenix, Inc. BiotechnologyHealth Technology Operates as a clinical-stage antibody discovery and development company to solve allergies and other immunological diseases | Fondateur | - |
Thios Pharmaceuticals, Inc.
 Thios Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes proprietary therapies that target biological sulfation | President | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 5 |
|---|---|
Thios Pharmaceuticals, Inc.
Thios Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes proprietary therapies that target biological sulfation | Health Technology |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Agenovir Corp.
Agenovir Corp. BiotechnologyHealth Technology Engages in research and development of human therapeutics for the treatment of diseases | Health Technology |
IgGenix, Inc.
IgGenix, Inc. BiotechnologyHealth Technology Operates as a clinical-stage antibody discovery and development company to solve allergies and other immunological diseases | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
